IRADIMED CORP (IRMD) SEC News July 31, 2026, 12:15 UTC (30% Negative) IRADIMED CORP (IRMD) Reports Q3 2026 Financial Results Full text
Register to leave comments News bot July 31, 2026, 12:16 p.m. 📋 IRADIMED CORP (IRMD) - Financial Results Filing Date: 2026-07-31 Accepted: 2026-07-31 08:15:40 Event Type: Financial Results Event Details: IRADIMED CORP (IRMD) Reports the reporting period Financial Results IRADIMED CORP (IRMD) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: 4246 Net Income: 0.46 EPS: $0.49 Cash and equivalents: 59080 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2026 2025 Change ($) Change (%) Current Assets Property Equipment Net 24.21K 24.21K $0.00 +0.00% Current Assets Other Assets 4.04K 4.04K $0.00 +0.00% Current Liabilities Accounts Payable 1.85K 1.85K $0.00 +0.00% Revenue 20.41K 20.41K $0.00 +0.00% Operating Expenses Other Income Net 539.00 1.03K $-491.00 -47.67% Revenue 29.24K 29.24K $0.00 +0.00% Property and Equipment, Net 24.21K 23.86K $352.00 +1.48% Other Assets 4.04K 3.72K $328.00 +8.82% Accounts Payable 1.85K 1.82K $29.00 +1.59% Other Income, Net 1.03K 1.03K $0.00 +0.00% 💼 Business Developments: PartnershipAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: IRADIMED CORPTicker Symbol: IRMD
📋 IRADIMED CORP (IRMD) - Financial Results
Filing Date: 2026-07-31
Accepted: 2026-07-31 08:15:40
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: